Piroxicam Capsules

Analgesic, Anti-Inflammatory & Anti-Pyretic · Hard Gelatin Capsules · 20mg

Trade Information

Minimum Order Qty	1,000,000 capsules
Capacity	100 Million Capsules per month
Strength	20mg
Private Labelling	Custom branding, artwork & market-specific labelling
Lead Time	45–60 days from order confirmation
Payment Terms	LC at sight, TT (advance / against documents)
Shipping	FOB / CIF to major international ports including Mombasa, Dar es Salaam, Lagos, Durban, Manila, Phnom Penh
Pharmacopoeia	BP, USP, IP compliant

Packing Options

Blister (Alu-Alu / Alu-PVC)
Strip pack
Bottle pack (HDPE)
Hospital bulk pack
Custom packing as per buyer requirement

Regulatory & Quality

Registration Status	Registered in multiple African, Asian, and CIS markets. Dossier available for new market registration.
Regulatory Dossiers	CTD / ACTD format dossiers available for submission to national drug authorities.
Stability Data	Zone IVa & IVb stability data available (tropical climate conditions, 30°C/65% RH & 30°C/75% RH)
WHO Prequalification	WHO-GMP Certified

Product Details

Composition	Piroxicam
Dosage Form	Hard Gelatin Capsules
Pack Size	10x10, Bottle of 100/500 / Custom packing available
Storage	Store below 30°C in a dry place, protected from light
Shelf Life	36 months from date of manufacture

Description

Piroxicam is a long-acting non-steroidal anti-inflammatory drug (NSAID) of the oxicam class. It is widely used for the management of chronic inflammatory and degenerative joint conditions, offering the convenience of once-daily dosing.

BioGalen manufactures Piroxicam Capsules 20mg for domestic and export markets. Piroxicam remains a widely prescribed NSAID across Africa, Asia, and Latin America due to its potent anti-inflammatory activity, long duration of action, and established clinical track record.

Mechanism of Action

Piroxicam belongs to the oxicam class of NSAIDs and inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, reducing prostaglandin and thromboxane synthesis at sites of inflammation. What distinguishes Piroxicam from other NSAIDs is its exceptionally long plasma half-life of 30–86 hours (average ~50 hours), which allows effective once-daily dosing and sustained anti-inflammatory activity over 24 hours. Beyond COX inhibition, Piroxicam also inhibits neutrophil aggregation and migration, reduces the production of superoxide radicals by polymorphonuclear leukocytes, and decreases the release of lysosomal enzymes — contributing to its particularly potent anti-inflammatory effect in chronic joint diseases. These multiple anti-inflammatory mechanisms make Piroxicam especially effective for chronic conditions like rheumatoid arthritis and osteoarthritis where sustained inflammation control is critical.

Indications

Rheumatoid arthritis
Osteoarthritis
Ankylosing spondylitis
Acute musculoskeletal disorders
Acute gout
Post-operative pain and inflammation

Available Variants

Piroxicam Capsules 20mg

Frequently Asked Questions

What advantage does Piroxicam offer over other NSAIDs like Diclofenac or Ibuprofen?

Piroxicam's unique advantage is once-daily dosing due to its long half-life (30–86 hours), compared to Diclofenac (twice or thrice daily) and Ibuprofen (three to four times daily). For patients with chronic arthritis who need long-term daily NSAID therapy, once-daily dosing significantly improves compliance. In markets where patient follow-up is challenging, this is a meaningful clinical advantage.

Why is Piroxicam still widely prescribed in Africa and Asia?

Piroxicam remains one of the top-prescribed NSAIDs in Sub-Saharan Africa, South Asia, and Southeast Asia. Its popularity is driven by once-daily convenience, potent anti-inflammatory action, decades of clinical familiarity among prescribers, and competitive pricing. It is included in many national essential medicines lists and is a standard item in hospital and clinic formularies.

What is the market positioning of Piroxicam versus newer NSAIDs?

While newer selective COX-2 inhibitors exist, they are significantly more expensive and not widely available in emerging markets. Piroxicam offers comparable anti-inflammatory efficacy at a fraction of the cost, making it the practical choice for healthcare systems with limited budgets. For B2B buyers, Piroxicam provides strong margins with consistent prescriber demand.

Is Piroxicam available in other dosage forms besides capsules?

BioGalen currently manufactures Piroxicam in 20mg hard gelatin capsules, which is the most widely prescribed formulation globally. The capsule form allows rapid absorption and is the standard dosage form specified in most tender requirements and essential medicines lists.

Interested in Piroxicam Capsules?

Get competitive pricing for bulk orders, private labelling, and contract manufacturing.

WhatsApp Enquiry Contact Us

Browse Categories

Browse by Dosage Form